PIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings

James S. Leathers, Domingo Balderramo, Jhon Prieto, Fernando Diehl, Esteban Gonzalez-Ballerga, Melina R. Ferreiro, Enrique Carrera, Fernando Barreyro, Javier Diaz-Ferrer, Dupinder Singh, Angelo Z. Mattos, Flair Carrilho, Jose D. Debes

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article numbere82345
JournalHepatitis Monthly
Volume18
Issue number10
DOIs
StatePublished - Oct 2018

Keywords

  • HCC
  • Hepatocellular carcinoma
  • Score
  • Sorafenib

Cite this